Aurinia Pharmaceuticals Inc. stock rating and score history
All changes in ratings, performance and outlook tracked over time.
Aurinia Pharmaceuticals Inc. stock price, chart patterns and momentum
Recent price movements, trend behaviour and momentum signals based on real-time market data.
What does Aurinia Pharmaceuticals Inc. do? Business model and key facts
Get the full picture of Aurinia Pharmaceuticals Inc.: what it builds, where it operates, and how it makes money.
Sector: Healthcare
Industry: Biotechnology
Employees (FY): 130
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.
Stocks related to Aurinia Pharmaceuticals Inc.
Selected based on industry alignment and relative market positioning.
Events and news impacting Aurinia Pharmaceuticals Inc. stock
Earnings, coporate decisions and industry developments that can affect the share price.
Aurinia Pharmaceuticals Inc. fundamentals and technical analysis
Financial fundamentals and technicals signals combined to access stability, momentum and market direction.
